Latest News
Proteomic Expression Profiles May Allow for Risk Stratification for Psychotic Disorders or Psychotic Episodes
Emotional Memory Retrieval Prior to Electroconvulsive Therapy in Patients With Major Depressive Disorder
Access to Opioid Use Disorder Treatment Dependent on Insurance Status
ADHD Prevalence Higher Among Blacks Than US Population
Loneliness and Social Isolation Linked to Poor Sleep Quality in Older Adults
SSRI Use Resolves Depression, Increases Recurrent Stroke Risk After ICH
Depressive Symptoms in Peripheral Artery Disease May Be Associated With Poorer Health Status
Substance Use Disorder Linked to Increased Risk for COVID-19
Atypical Antipsychotics May Dysregulate Immune Response, Increase Risk for COVID-19
mRNA Expression Signatures for Identifying Response to Antidepressant Therapies
Meta-Analysis Links PTSD to Increased Dementia Risk
Teen Exposure to Bisphenol-A Associated With ADHD
COVID-19: Physical Activity May Improve Well-Being During Quarantine
Intermittent Negative Pressure Therapy May Help Sleep Apnea Sufferers Feel More Rested
H1N1 Vaccine Exposure During Fetal Life Not Associated With Autism Spectrum Disorder
Workplace Sexual Harassment Tied to Suicide Risk
Psychosis Relapse Common During Assured Antipsychotic Treatment
Individuals With a High Genetic Risk for Alzheimer’s Disease Have Altered Sleep Patterns
Sleep Wearables Generate Stable Estimates
Latest Features
American Psychiatric Association Publishes Updated Practice Guidelines for the Treatment of Schizophrenia
Since publication of the last full practice guideline and guideline watch on schizophrenia, there have been a multitude of studies on new pharmacological and nonpharmacological treatments for schizophrenia.
Pharmacogenetic Testing: Does it Improve Therapy in Patients With MDD?
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Study Author Q&A: Alterations of the HPA Axis in Major Depressive Disorder
This systematic review further explores whether alterations of the HPA axis that are commonly found in patients with major depressive disorder are due to early life stress or whether the alterations are caused by the MDD itself.
Ethical Considerations in Prescribing Unproven Therapies for COVID-19
Meeting public demand for an urgently needed effective medication quickly and safely during a pandemic involves difficult tradeoffs.
The Rising Incidence of Burnout Among Mental Health Professionals
Burnout is on the rise among psychiatrists. Explore the driving factors behind this trend and learn key interventions to avoid its negative effects.
-
Loading...
-
Loading...
